Search Results - "Sarmiento Maldonado, Mauricio"

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis by Sarmiento Maldonado, Mauricio, Ramírez Villanueva, Pablo, Bertín Cortes-Monroy, Pablo, Jara Arias, Veronica, Soto Donoso, Katherine, Uribe Gonzalez, Pablo, Ocqueteau Tachini, Mauricio, Perez-Simón, Jose Antonio

“…Ruxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has revealed…”
Get full text

Retrospective study comparing low-dose versus standard dose of bortezomib in patients with multiple myeloma by Espinoza Zelada, Marcela, Befferman Cordova, Nicole, Ocqueteau Tachini, Mauricio, Ramírez Villanueva, Pablo, Galleguillos M, Mauricio, Sarmiento Maldonado, Mauricio

“…Bortezomib is a selective inhibitor of the proteosoma that is used in multiple myeloma. In combination with other antineoplastic drugs, it has a…”
Get full text

Treatment of thrombotic thrombocytopenic purpura with rituximab. Report of eight cases by Sarmiento Maldonado, Mauricio, Bertín Cortés-Monroy, Pablo, Lira Vergara, Pablo, Rodríguez Ingles, María Alejandra, García Rodríguez, María José, Ramírez Villanueva, Pablo, Ocqueteau Tachini, Mauricio

“…Thrombotic thrombocytopenic purpura, an immune/non-immune thrombotic microangiopathy (TTP/TMA) is associated with high morbidity and mortality, even with…”
Get full text

Nutritional evolution during the early stages of hematopoietic stem cell transplantation: importance of the phase angle by Valdés Boccardo, Silvana, Sarmiento Maldonado, Mauricio, Velasco Fuentes, Nicolás

“…Introduction: the aim of this study is to compare the changes in anthropometry, dynamometry and bioelectrical impedance analysis (BIA) of patients undergoing…”
Get full text

Historical Analysis of a Cohort of Chilean Patients Treated with Autologous Stem Cell Transplantation Since 1993: Optimization of Stem Cell Collections, Risk Factors for Poor Mobilizers and Efficient Plerixafor Use by Maldonado, Mauricio Sarmiento, Veronica, Jara, Arellano, Silvana, Katherine, Soto, Lorca, Carla, Pizarro, Isabel, Bertin, Pablo, Galleguillos, Mauricio, Rivera, Elizabeth, Rodriguez, Isabel, Beffermann, Nicole, Ocqueteau, Mauricio, Pereira, Jaime

“…Introduction Autologous hematopoietic transplantation (autoHT) is an effective treatment in myeloma and lymphoma patients. To perform it, an adequate harvest…”
Get full text

Time to Change Our Practice: Experience in the Treatment of Steroid Refractory Graft Versus Host Disease in a Universitary Hospital in Chile by Triantafilo, Nicolas, Maldonado, Mauricio Sarmiento, Palacios, Felipe, Campbell, James, Sandoval, Vicente, Rojas, Andres, Veronica, Jara, Katherine, Soto, Arellano, Silvana, Lorca, Carla, Pizarro, Isabel, Rivera, Elizabeth, Galleguillos, Mauricio, Rodriguez, Isabel, Bertin, Pablo, Ocqueteau, Mauricio, Pereira, Jaime

“…Introduction Steroids refractory (SR) acute (a) or chronic (c) graft versus host disease (GVHD) carries morbidity and lethality. Treatment algorithms varies…”
Get full text

Response and survival in acute myeloid leukemia patients not candidates to transplantation treated with azacitidine versus palliative treatment: a retrospective study by Sarmiento Maldonado, Mauricio, Ocqueteau Tachini, Mauricio, Pilcante, Javier, Ramírez Villanueva, Pablo

“…Acute myeloid leukemia has a high mortality if untreated. Hematopoietic stem cell transplantation is the only curative treatment so far. Patients who are not…”
Get full text

Experiencia de un hospital universitario en el manejo de púrpura trombótico trombocitopénico-microangiopatía trombótica no inmune refractaria o en recaída tratado con rituximab: Report of eight cases by Sarmiento Maldonado, Mauricio, Bertín Cortés-Monroy, Pablo, Lira Vergara, Pablo, Rodríguez Ingles, María Alejandra, García Rodríguez, María José, Ramírez Villanueva, Pablo, Ocqueteau Tachini, Mauricio

Get full text

Response and survival in acute myeloid leukemia patients not candidates to transplantation treated with azacitidine versus palliative treatment: a retrospective study by Mauricio Sarmiento Maldonado, Mauricio Ocqueteau Tachini, Javier Pilcante, Pablo Ramírez Villanueva

“…INTRODUCCIÓN La leucemia mieloide aguda tiene una alta mortalidad sin tratamiento. El trasplante hematopoyético es la única estrategia curativa hasta ahora…”
Get full text

Experiencia de un hospital universitario en el manejo de púrpura trombótico trombocitopénico-microangiopatía trombótica no inmune refractaria o en recaída tratado con rituximab: Report of eight cases by Sarmiento Maldonado, Mauricio, Bertín Cortés-Monroy, Pablo, Lira Vergara, Pablo, Rodríguez Ingles, María Alejandra, García Rodríguez, María José, Ramírez Villanueva, Pablo, Ocqueteau Tachini, Mauricio

Get full text

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis by Sarmiento Maldonado, Mauricio, Ramírez Villanueva, Pablo, Bertín Cortes-Monroy, Pablo, Jara Arias, Veronica, Soto Donoso, Katherine, Uribe Gonzalez, Pablo, Ocqueteau Tachini, Mauricio, Perez-Simón, Jose Antonio

“…BackgroundRuxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has…”
Get full text